Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.

Jalink MB, Langley JM, Dodds L, Andreou P.

Pediatr Infect Dis J. 2019 Nov;38(11):1121-1125. doi: 10.1097/INF.0000000000002432.

PMID:
31425330
2.

Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein.

Sharkey K, Beernink PT, Langley JM, Gantt S, Quach C, Dold C, Liu Q, Galvan M, Granoff DM.

mSphere. 2019 Jul 3;4(4). pii: e00393-19. doi: 10.1128/mSphere.00393-19.

3.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

LeBlanc JJ, ElSherif M, Mulpuru S, Warhuus M, Ambrose A, Andrew M, Boivin G, Bowie W, Chit A, Dos Santos G, Green K, Halperin SA, Hatchette TF, Ibarguchi B, Johnstone J, Katz K, Langley JM, Lagacé-Wiens P, Loeb M, Lund A, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA.

J Med Microbiol. 2019 Jul 2. doi: 10.1099/jmm.0.001032. [Epub ahead of print]

PMID:
31264957
4.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.

Mulpuru S, Li L, Ye L, Hatchette T, Andrew MK, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).

Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.

PMID:
30616737
5.

Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.

Cattapan A, Browne K, Halperin DM, Di Castri A, Fullsack P, Graham J, Langley JM, Taylor BA, McNeil SA, Halperin SA.

Vaccine. 2019 Jan 7;37(2):289-295. doi: 10.1016/j.vaccine.2018.11.014. Epub 2018 Dec 7.

PMID:
30528592
6.

Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16.

Boyd DA, Mataseje LF, Pelude L, Mitchell R, Bryce E, Roscoe D, Embree J, Katz K, Kibsey P, Lavallee C, Simor AE, Taylor G, Turgeon N, Langley JM, Amaratunga K, Mulvey MR; Canadian Nosocomial Infection Surveillance Program .

J Antimicrob Chemother. 2019 Feb 1;74(2):315-320. doi: 10.1093/jac/dky416.

PMID:
30312401
7.

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.

Halperin SA, Langley JM, Ye L, MacKinnon-Cameron D, Elsherif M, Allen VM, Smith B, Halperin BA, McNeil SA, Vanderkooi OG, Dwinnell S, Wilson RD, Tapiero B, Boucher M, Le Saux N, Gruslin A, Vaudry W, Chandra S, Dobson S, Money D.

Clin Infect Dis. 2018 Sep 14;67(7):1063-1071. doi: 10.1093/cid/ciy244.

PMID:
30010773
8.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

9.

Pediatric Investigators Collaborative Network on Infections in Canada Study of Respiratory Syncytial Virus-associated Deaths in Pediatric Patients in Canada, 2003-2013.

Tam J, Papenburg J, Fanella S, Asner S, Barton M, Bergeron C, Desai S, Hui C, Foo C, Langley JM, Leifso K, Ma ML, Pernica J, Robinson J, Singh R, Tapiero B, Allen U.

Clin Infect Dis. 2019 Jan 1;68(1):113-119. doi: 10.1093/cid/ciy413.

PMID:
29788036
10.

Contact among healthcare workers in the hospital setting: developing the evidence base for innovative approaches to infection control.

English KM, Langley JM, McGeer A, Hupert N, Tellier R, Henry B, Halperin SA, Johnston L, Pourbohloul B.

BMC Infect Dis. 2018 Apr 17;18(1):184. doi: 10.1186/s12879-018-3093-x.

11.

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.

Langley JM, MacDonald LD, Weir GM, MacKinnon-Cameron D, Ye L, McNeil S, Schepens B, Saelens X, Stanford MM, Halperin SA.

J Infect Dis. 2018 Jul 2;218(3):378-387. doi: 10.1093/infdis/jiy177.

12.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

Nichols MK, Andrew MK, Hatchette TF, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Lagacé-Wiens P, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Powis J, Richardson D, Schuind A, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN).

Vaccine. 2018 Apr 12;36(16):2166-2175. doi: 10.1016/j.vaccine.2018.02.093. Epub 2018 Mar 13.

PMID:
29548608
13.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.

Andrew MK, Shinde V, Hatchette T, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Nichols MK, Powis J, Richardson D, Semret M, Stiver G, Trottier S, Valiquette L, Webster D, Ye L, McNeil SA; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN).

BMC Infect Dis. 2017 Dec 29;17(1):805. doi: 10.1186/s12879-017-2905-8.

14.

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.

Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Prégaldien JL, Ginis J, Staerke NB, Perez JL; B1971009 and B1971016 Trial Investigators.

N Engl J Med. 2017 Dec 14;377(24):2349-2362. doi: 10.1056/NEJMoa1614474.

15.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK.

Clin Infect Dis. 2017 Nov 29;65(12):1963-1973. doi: 10.1093/cid/cix959.

16.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK.

Clin Infect Dis. 2017 Nov 29;65(12):e45-e80. doi: 10.1093/cid/cix669.

17.

Vaccine Prevention of Respiratory Syncytial Virus Infection in Older Adults: The Work Continues.

Langley JM.

J Infect Dis. 2017 Dec 12;216(11):1334-1336. doi: 10.1093/infdis/jix504. No abstract available.

18.

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform.

MacDonald LD, MacKay A, Kaliaperumal V, Weir G, Penwell A, Rajagopalan R, Langley JM, Halperin S, Mansour M, Stanford MM.

Hum Vaccin Immunother. 2018 Jan 2;14(1):59-66. doi: 10.1080/21645515.2017.1375637. Epub 2017 Oct 30.

19.

Risk factors for surgical site infection following cesarean delivery: a retrospective cohort study.

Ketcheson F, Woolcott C, Allen V, Langley JM.

CMAJ Open. 2017 Jul 11;5(3):E546-E556. doi: 10.9778/cmajo.20160164.

20.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.

ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, Alimonti J, Rudge TL, Sabourin C, Silvera P, Hooper JW, Kwilas SA, Kilgore N, Badorrek C, Ramsey WJ, Heppner DG, Kemp T, Monath TP, Nowak T, McNeil SA, Langley JM, Halperin SA; Canadian Immunization Research Network.

CMAJ. 2017 Jun 19;189(24):E819-E827. doi: 10.1503/cmaj.170074.

21.

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.

Delea TE, Weycker D, Atwood M, Neame D, Alvarez FP, Forget E, Langley JM, Chit A.

PLoS One. 2017 May 4;12(5):e0175721. doi: 10.1371/journal.pone.0175721. eCollection 2017.

22.

Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.

MacDougall DM, Langley JM, Li L, Ye L, MacKinnon-Cameron D, Top KA, McNeil SA, Halperin BA, Swain A, Bettinger JA, Dubé E, De Serres G, Halperin SA; Canadian Immunization Research Network.

Vaccine. 2017 Apr 25;35(18):2520-2530. doi: 10.1016/j.vaccine.2017.02.011. Epub 2017 Mar 24.

PMID:
28347501
23.

Reply to Weber, von Cube, Sommer, Wolkewitz: Necessity of a Competing Risk Approach in Risk Factor Analysis of Central-Line-Associated Bloodstream Infection.

Kuhle S, Carter JH, Kirkland S, Langley JM, Maguire B, Smith B.

Infect Control Hosp Epidemiol. 2017 Apr;38(4):511. doi: 10.1017/ice.2016.331. Epub 2017 Jan 31. No abstract available.

PMID:
28137334
24.

Assessing the risk of intussusception and rotavirus vaccine safety in Canada.

Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM, Deeks SL.

Hum Vaccin Immunother. 2017 Mar 4;13(3):703-710. doi: 10.1080/21645515.2016.1240846. Epub 2016 Nov 11.

25.

The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.

Slaunwhite JM, Smith SM, Halperin BA, Langley JM, Halperin SA.

Vaccine. 2016 Nov 11;34(47):5704-5707. doi: 10.1016/j.vaccine.2016.08.083. Epub 2016 Sep 21.

PMID:
27665353
26.

Toward Standardizing a Lexicon of Infectious Disease Modeling Terms.

Milwid R, Steriu A, Arino J, Heffernan J, Hyder A, Schanzer D, Gardner E, Haworth-Brockman M, Isfeld-Kiely H, Langley JM, Moghadas SM.

Front Public Health. 2016 Sep 28;4:213. eCollection 2016. Review.

27.

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.

Langley JM, Aggarwal N, Toma A, Halperin SA, McNeil SA, Fissette L, Dewé W, Leyssen M, Toussaint JF, Dieussaert I.

J Infect Dis. 2017 Jan 1;215(1):24-33. doi: 10.1093/infdis/jiw453. Epub 2016 Sep 29.

28.

Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.

Langley JM, MacDougall DM, Halperin BA, Swain A, Halperin SA, Top KA, McNeil SA, MacKinnon-Cameron D, Marty K, De Serres G, Dubé E, Bettinger JA.

Vaccine. 2016 Jul 25;34(34):4046-9. doi: 10.1016/j.vaccine.2016.06.025. Epub 2016 Jun 11.

PMID:
27302338
29.

Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial.

MacDougall DM, Halperin BA, Langley JM, McNeil SA, MacKinnon-Cameron D, Li L, Halperin SA.

Hum Vaccin Immunother. 2016 Apr 2;12(4):879-85. doi: 10.1080/21645515.2015.1130193.

30.

Risk Factors for Central Venous Catheter-Associated Bloodstream Infection in Pediatric Patients: A Cohort Study.

Carter JH, Langley JM, Kuhle S, Kirkland S.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):939-45. doi: 10.1017/ice.2016.83. Epub 2016 May 3.

PMID:
27139311
31.

Estimating Respiratory Syncytial Virus-associated Hospitalization in the First Year of Life Among Infants Born at 32-35 Weeks of Gestation.

Ryan VM, Langley JM, Dodds L, Andreou P.

Pediatr Infect Dis J. 2016 Aug;35(8):851-5. doi: 10.1097/INF.0000000000001186.

PMID:
27124687
32.

Economic evaluation of vaccines in Canada: A systematic review.

Chit A, Lee JK, Shim M, Nguyen VH, Grootendorst P, Wu J, Van Exan R, Langley JM.

Hum Vaccin Immunother. 2016 May 3;12(5):1257-64. doi: 10.1080/21645515.2015.1137405. Epub 2016 Feb 18. Review.

33.

Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers.

MacDougall D, Halperin BA, Isenor J, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

Hum Vaccin Immunother. 2016 Mar 3;12(3):623-31. doi: 10.1080/21645515.2015.1093714.

34.

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

Coleman BL, McNeil SA, Langley JM, Halperin SA, McGeer AJ.

Vaccine. 2015 Nov 27;33(48):6635-40. doi: 10.1016/j.vaccine.2015.10.095. Epub 2015 Oct 31.

PMID:
26529074
35.

Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.

MacDougall DM, Halperin BA, Langley JM, MacKinnon-Cameron D, Li L, Halperin SA; Maritime Universal Rotavirus Vaccination Program (MURVP).

Vaccine. 2016 Jan 27;34(5):687-695. doi: 10.1016/j.vaccine.2015.09.089. Epub 2015 Oct 14.

PMID:
26458809
36.

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers.

MacDougall DM, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

BMJ Open. 2015 Sep 29;5(9):e009062. doi: 10.1136/bmjopen-2015-009062.

37.

Healthcare-Associated Clostridium difficile Infections and Strain Diversity in Pediatric Hospitals in the Canadian Nosocomial Infection Surveillance Program, 2007-2011.

Le Saux N, Gravel D, Mulvey M, Moore D, Langley JM, Richardson S, Quach C, Choi KB, Miller M, Katz K; Canadian Nosocomial Infection Surveillance Program.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):e151-4. doi: 10.1093/jpids/piv011. Epub 2015 Mar 19.

PMID:
26407250
38.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to know.

Halperin BA, MacDougall D, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

Vaccine. 2015 Nov 27;33(48):6840-8. doi: 10.1016/j.vaccine.2015.09.012. Epub 2015 Sep 21.

PMID:
26392011
39.

Reducing infection transmission in the playroom: Balancing patient safety and family-centered care.

Ivany A, LeBlanc C, Grisdale M, Maxwell B, Langley JM.

Am J Infect Control. 2016 Jan 1;44(1):61-5. doi: 10.1016/j.ajic.2015.07.036. Epub 2015 Sep 1.

PMID:
26341403
40.

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial.

Langley JM, Wang L, Aggarwal N, Bueso A, Chandrasekaran V, Cousin L, Halperin SA, Li P, Liu A, McNeil S, Mendez LP, Rivera L, Innis BL, Jain VK.

J Pediatric Infect Dis Soc. 2015 Sep;4(3):242-51. doi: 10.1093/jpids/piu098. Epub 2014 Oct 20.

41.

Tick bites in the Lyme light.

Barton-Forbes M, Leonard E, Lindsay LR, Langley JM, Koffi JK, Ogden NH.

Paediatr Child Health. 2015 Jun-Jul;20(5):237-8. No abstract available. Erratum in: Paediatr Child Health. 2015 Aug-Sep;20(6):335.

42.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

MacDougall D, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA.

Hum Vaccin Immunother. 2015;11(9):2167-79. doi: 10.1080/21645515.2015.1046662. Epub 2015 Jun 19.

43.

Against vaccine assay secrecy.

Herder M, Hatchette TF, Halperin SA, Langley JM.

Hum Vaccin Immunother. 2015;11(2):498-503. doi: 10.4161/21645515.2014.980194.

44.

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization.

Sanford C, Langley JM, Halperin SA, Zelman M, Mvrvp.

Hum Vaccin Immunother. 2015;11(4):870-4. doi: 10.1080/21645515.2015.1012028.

45.

Adolescent immunization - Protecting youth and preparing them for a healthy future.

Langley JM.

Int J Pediatr Adolesc Med. 2015 Mar;2(1):1-6. doi: 10.1016/j.ijpam.2015.02.001. Epub 2015 Mar 20. Review.

46.

Canadian vaccine research networks: Vaccine safety resources for Canada.

McCarthy J, Halperin SA, Bettinger JA, Langley JM, Crowcroft NS, Deeks S, Kwong JC, De Serres G, Top K, McNeil S, Scheifele DW; Canadian Immunization Research Network (CIRN) Investigators.

Can Commun Dis Rep. 2015 Feb 20;41(Suppl 1):18-23. eCollection 2015 Feb 20.

47.

Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trial.

Langley JM, Frenette L, Jeanfreau R, Halperin SA, Kyle M, Chu L, McNeil S, Dramé M, Moris P, Fries L, Vaughn DW.

Vaccine. 2015 Jan 15;33(4):559-67. doi: 10.1016/j.vaccine.2014.11.018. Epub 2014 Nov 21.

48.

Implementation of a universal rotavirus vaccination program: comparison of two delivery systems.

Zelman M, Sanford C, Neatby A, Halperin BA, MacDougall D, Rowswell C, Langley JM, Halperin SA; Maritime Universal Rotavirus Vaccination Program (MURVP).

BMC Public Health. 2014 Sep 2;14:908. doi: 10.1186/1471-2458-14-908.

49.

Incorporating economic evaluation into immunization decision making in Canada: a workshop.

Langley JM, Krahn M, Husereau D, Spika J, Fisman DN, Chit A, Van Exan R.

Expert Rev Vaccines. 2014 Nov;13(11):1291-6. doi: 10.1586/14760584.2014.939637. Epub 2014 Jul 23. No abstract available.

50.

Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls.

Barton M, O'Brien K, Robinson JL, Davies DH, Simpson K, Asztalos E, Langley JM, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Richardson SE.

BMC Infect Dis. 2014 Jun 12;14:327. doi: 10.1186/1471-2334-14-327.

Supplemental Content

Loading ...
Support Center